Clinical Research Directory
Browse clinical research sites, groups, and studies.
Psychopharmacotherapy for Depressive Patients
Sponsor: Chonnam National University Hospital
Summary
The primary purpose of this study is to compare the short (12 week) and long-term (1-year) efficacy and the tolerability between stepwise psychopharmacotherapy and antidepressant monotherapy for 12 weeks in adult patients with major depressive disorders, stratified by the multimodal serum biomarker scores.
Official title: A Randomized Clinical Trial of Response to Psychopharmacotherapy According to Multimodal Serum Biomarkers in Depressive Patients
Key Details
Gender
All
Age Range
19 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2022-08-03
Completion Date
2030-12-31
Last Updated
2024-04-18
Healthy Volunteers
No
Conditions
Interventions
stepwise pharmacotherapy
In the stepwise pharmacotherapy group, treatment strategies (augmentation with antipsychotics (aripiprazole), augmentation with mood stabilizer (lithium),combination (mirtazapine)) will be determined every 3 weeks.
antidepressant monotherapy group
In the antidepressant monotherapy group, dosage escalation will be determined every 3 weeks.
Locations (1)
Chonnam National University Hospital
Gwangju, South Korea